11.19
price down icon2.06%   -0.235
after-market Handel nachbörslich: 11.19 0.005 +0.04%
loading

Finanzdaten der Omeros Corporation-Aktie (OMER)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Selling, General, and Administrative
0.50%
10.40
10.35 11.12 12.34 11.32
Costs And Expenses
18.43%
26.39
32.35 34.97 35.66 35.41
Operating Income/Loss
18.43%
-26.39
-32.35 -34.97 -35.66 -35.41
Income/Loss From Continuing Operations Before Tax
16.45%
-21.24
-25.42 -33.46 -23.17 -37.11
Income/Loss From Continuing Operations After Tax
17.95%
-21.24
-25.89 -37.56 -36.54 -37.11
Income/Loss From Discontinued Operations, Net Of Tax
2,176%
-9.674
0.466 4.105 5.183 4.881
Net Income/Loss
21.61%
-30.92
-25.42 -33.46 -31.36 -32.23
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
13.11%
66.26
58.59 58.06 -0.0611 57.95
Basic Earnings Per Share
9.30%
-0.47
-0.43 -0.58 -0.55 -0.56
Diluted Earnings Per Share
9.30%
-0.47
-0.43 -0.58 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):